CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ceftizoxime Sodium

头孢唑肟钠 杂质对照品Ceftizoxime Sodium Impurities

30 个杂质条目30 impurity entries

本页汇总 头孢唑肟钠 的 30 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 30 impurity reference standards of Ceftizoxime Sodium. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 头孢唑肟钠(Ceftizoxime Sodium)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStructural identification and characterization of impurities in ceftizoxime sodium
    Journal of pharmaceutical and biomedical analysis · 2007 · Bharathi Ch et al.  ·  PMID 16950586  ·  DOI
  2. 分析方法Analytical MethodsValidation and Application of an LC-MS-MS Method for the Determination of Ceftizoxime in Human Serum and Urine
    Journal of chromatographic science · 2016 · Wang L et al.  ·  PMID 26896348  ·  DOI
  3. 分析方法Analytical MethodsStability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions
    American journal of hospital pharmacy · 1985 · Bosso JA, Townsend RJ  ·  PMID 3864367

头孢唑肟钠 —— 原料药与杂质对照品Ceftizoxime Sodium — drug substance & impurities

共 30 个条目(含原料药本体)30 items incl. the drug substance
Ceftizoxime structure
—
头孢唑肟Ceftizoxime
Ceftizoxime
CAS No.68401-81-0
Chemical FormulaC13H13N5O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Sodium Salt structure
—
头孢唑肟钠 钠盐Ceftizoxime Sodium Sodium Salt
Ceftizoxime Sodium Sodium Salt
CAS No.68401-82-1
Chemical FormulaC13H12N5O5S2-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 1 structure
1
头孢唑肟钠杂质1Ceftizoxime Sodium Impurity 1
Ceftizoxime Sodium Impurity 1
CAS No.929101-91-7
Chemical FormulaC20H19N7O7S3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 2 structure
2
头孢唑肟钠杂质2Ceftizoxime Sodium Impurity 2
Ceftizoxime Sodium Impurity 2
CAS No.929101-93-9
Chemical FormulaC19H18N8O7S3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 5 structure
5
头孢唑肟钠杂质5Ceftizoxime Sodium Impurity 5
Ceftizoxime Sodium Impurity 5
CAS No.929101-89-3
Chemical FormulaC13H15N5O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 9 structure
9
头孢唑肟钠杂质9Ceftizoxime Sodium Impurity 9
Ceftizoxime Sodium Impurity 9
CAS No.36923-17-8
Chemical FormulaC7H8N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 10 structure
10
头孢唑肟钠杂质10Ceftizoxime Sodium Impurity 10
Ceftizoxime Sodium Impurity 10
CAS No.79226-66-7
Chemical FormulaC13H13N5O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 11 Monomer structure
11
头孢唑肟钠杂质11 单体Ceftizoxime Sodium Impurity 11 Monomer
Ceftizoxime Sodium Impurity 11 Monomer
CAS No.68403-31-6
Chemical FormulaC13H13N5O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 11 (E-Ceftizoxime Sodium) structure
11
头孢唑肟钠杂质11 (E-头孢唑肟钠)Ceftizoxime Sodium Impurity 11 (E-Ceftizoxime Sodium)
Ceftizoxime Sodium Impurity 11 (E-Ceftizoxime Sodium)
CAS No.97164-53-9
Chemical FormulaC13H12N5NaO5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 12 structure
12
头孢唑肟钠杂质12Ceftizoxime Sodium Impurity 12
Ceftizoxime Sodium Impurity 12
CAS No.107438-59-5
Chemical FormulaC14H13N5O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 16 structure
16
头孢唑肟钠杂质16Ceftizoxime Sodium Impurity 16
Ceftizoxime Sodium Impurity 16
CAS No.2630907-20-7
Chemical FormulaC13H13N5O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 19 structure
19
头孢唑肟钠杂质19Ceftizoxime Sodium Impurity 19
Ceftizoxime Sodium Impurity 19
CAS No.102044-69-9
Chemical FormulaC13H13N5O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 25 structure
25
头孢唑肟钠杂质25Ceftizoxime Sodium Impurity 25
Ceftizoxime Sodium Impurity 25
CAS No.162208-27-7
Chemical FormulaC10H16N3O5PS2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 28 structure
28
头孢唑肟钠杂质28Ceftizoxime Sodium Impurity 28
Ceftizoxime Sodium Impurity 28
CAS No.105216-74-8
Chemical FormulaC13H11F2N5O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 34 structure
34
头孢唑肟钠杂质34Ceftizoxime Sodium Impurity 34
Ceftizoxime Sodium Impurity 34
CAS No.84994-24-1
Chemical FormulaC13H10N4O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 35 structure
35
头孢唑肟钠杂质35Ceftizoxime Sodium Impurity 35
Ceftizoxime Sodium Impurity 35
CAS No.64918-77-0
Chemical FormulaC7H8N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 39 structure
39
头孢唑肟钠杂质39Ceftizoxime Sodium Impurity 39
Ceftizoxime Sodium Impurity 39
CAS No.54639-48-4
Chemical FormulaC28H24N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 46 structure
46
头孢唑肟钠杂质46Ceftizoxime Sodium Impurity 46
Ceftizoxime Sodium Impurity 46
CAS No.104301-63-5
Chemical FormulaC8H10N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 48 structure
48
头孢唑肟钠杂质48Ceftizoxime Sodium Impurity 48
Ceftizoxime Sodium Impurity 48
CAS No.79601-96-0
Chemical FormulaC7H8N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 49 structure
49
头孢唑肟钠杂质49Ceftizoxime Sodium Impurity 49
Ceftizoxime Sodium Impurity 49
CAS No.68403-70-3
Chemical FormulaC7H10N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 50 structure
50
头孢唑肟钠杂质50Ceftizoxime Sodium Impurity 50
Ceftizoxime Sodium Impurity 50
CAS No.68881-44-7
Chemical FormulaC19H23N5O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 51 structure
51
头孢唑肟钠杂质51Ceftizoxime Sodium Impurity 51
Ceftizoxime Sodium Impurity 51
CAS No.1942004-69-4
Chemical FormulaC13H15N5O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 55 structure
55
头孢唑肟钠杂质55Ceftizoxime Sodium Impurity 55
Ceftizoxime Sodium Impurity 55
CAS No.2630910-00-6
Chemical FormulaC13H17N5O8S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 58 structure
58
头孢唑肟钠杂质58Ceftizoxime Sodium Impurity 58
Ceftizoxime Sodium Impurity 58
CAS No.1932625-97-2
Chemical FormulaC7H8N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 62 structure
62
头孢唑肟钠杂质62Ceftizoxime Sodium Impurity 62
Ceftizoxime Sodium Impurity 62
CAS No.740066-20-0
Chemical FormulaC14H14N6O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 63 structure
63
头孢唑肟钠杂质63Ceftizoxime Sodium Impurity 63
Ceftizoxime Sodium Impurity 63
CAS No.1821068-16-9
Chemical FormulaC9H13N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 64 structure
64
头孢唑肟钠杂质64Ceftizoxime Sodium Impurity 64
Ceftizoxime Sodium Impurity 64
CAS No.685850-97-9
Chemical FormulaC10H10N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 66 structure
66
头孢唑肟钠杂质66Ceftizoxime Sodium Impurity 66
Ceftizoxime Sodium Impurity 66
CAS No.74250-13-8
Chemical FormulaC13H12BrN5O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 69 structure
69
头孢唑肟钠杂质69Ceftizoxime Sodium Impurity 69
Ceftizoxime Sodium Impurity 69
CAS No.51761-81-0
Chemical FormulaC28H24N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftizoxime Sodium Impurity 78 structure
78
头孢唑肟钠杂质78Ceftizoxime Sodium Impurity 78
Ceftizoxime Sodium Impurity 78
CAS No.90712-49-5
Chemical FormulaC7H8N2O3S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

头孢唑肟钠 —— 研究文献与合成路线Ceftizoxime Sodium — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 头孢唑肟钠 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ceftizoxime Sodium. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Structural identification and characterization of impurities in ceftizoxime sodium
    Bharathi Ch, Prasad ChS, Bharathi DV, et al. · Journal of pharmaceutical and biomedical analysis · 2007 · 被引 10cited 10

合成与制备工艺专利Synthesis & process patents

  1. CEFTIZOXIME SODIUM CRYSTALLINE HYDRATE, PREPARATION METHODS AND USES THEREOF
    LIU LI · 公开号 WO2011113361WO2011113361 · 2011
  2. High-purity ceftizoxime sodium and preparation thereof
    LINGGANG TAO · 公开号 CN101348492CN101348492 · 2009
  3. Ceftizoxime sodium compound preparation
    LI HONGMEI · 公开号 CN1712008CN1712008 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

头孢唑肟钠 杂质谱研究要点Ceftizoxime Sodium — impurity profiling notes

下面这些是拿到 头孢唑肟钠 的 30 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 30 impurity entries for Ceftizoxime Sodium, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances